$10.2M NIH grant awarded to study risk factors for malignant arrhythmias in mitral valve prolapse

The grant will cover the manufacturing development of therapies by NK:IO in collaboration with the Cell and Gene Therapy Catapult. Credit: crystal light via Shutterstock. Innovate

NEW YORK CITY — Clinical notes for patients with substance use disorder (SUD) contained stigmatizing language — such as “junkie,” “dirty user,” and “this drunk”